| P50 | author | Lois Biener | Q50142010 |
| P2093 | author name string | Karen Bogen | |
| P2860 | cites work | Effect of smokeless tobacco (snus) on smoking and public health in Sweden | Q24678371 |
| | European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health | Q24678392 |
| | The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. | Q34376467 |
| | Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study | Q34627885 |
| | "Not safe" is not enough: smokers have a right to know more than there is no safe tobacco product | Q35578029 |
| | Smokeless tobacco use: harm reduction or induction approach? | Q35650428 |
| | Smokeless tobacco use 1992-2002: trends and measurement in the Current Population Survey-Tobacco Use Supplements | Q36930321 |
| | Role of snus in initiation and cessation of tobacco smoking in Sweden. | Q36930343 |
| | Epidemiologic perspectives on smokeless tobacco marketing and population harm | Q37005352 |
| | The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US | Q37024750 |
| | Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco | Q37467562 |
| | Smokers' beliefs about the relative safety of other tobacco products: findings from the ITC collaboration | Q46944584 |
| | Trends in smokeless tobacco use among adults and adolescents in the United States | Q61851280 |
| | Public health implications of smokeless tobacco use as a harm reduction strategy | Q79182547 |
| P433 | issue | 10 | |
| P921 | main subject | snus | Q842813 |
| | Camel | Q878241 |
| P304 | page(s) | 1154-1159 | |
| P577 | publication date | 2009-06-29 | |
| P1433 | published in | Nicotine and Tobacco Research | Q15762854 |
| P1476 | title | Receptivity to Taboka and Camel Snus in a U.S. test market | |
| P478 | volume | 11 | |